Live Price
Live Volume
Chart Volume 0
Volume 0
5 secAlnylam Pharmaceuticals Market Segments
Overnight
+0.00(+0.00%)
| Open | $159.80 |
|---|---|
| Close | $159.80 |
| Low | $159.80 |
| Low Change | 0.00 (0.00%) |
| High | $159.80 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 100 |
| Dollar Volume | $15.98K |
After Hours
+1.06(+0.67%)
| Open | $158.00 |
|---|---|
| Close | $159.06 |
| Low | $158.00 |
| Low Change | 0.00 (0.00%) |
| High | $160.00 |
| High Change | +2.00 (+1.27%) |
| Range | $2.00 |
| Volume | 779.664K |
| Dollar Volume | $124.01M |
Regular Trading Hours
-5.11(-3.13%)
| Open | $163.10 |
|---|---|
| Close | $157.99 |
| Low | $156.00 |
| Low Change | -7.10 (-4.35%) |
| High | $163.90 |
| High Change | +0.80 (+0.49%) |
| Range | $7.90 |
| Volume | 3.97M |
| Dollar Volume | $627.19M |
Premarket
-2.07(-1.25%)
| Open | $166.06 |
|---|---|
| Close | $163.99 |
| Low | $163.00 |
| Low Change | -3.06 (-1.84%) |
| High | $166.50 |
| High Change | +0.44 (+0.26%) |
| Range | $3.50 |
| Volume | 12.512K |
| Dollar Volume | $2.05M |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
*No Trades in Segment
Premarket Yesterday
*No Trades in Segment
Alnylam Pharmaceuticals News
2 months agoinvesting.comWhy is Alnylam Pharmaceuticals stock sliding today?
2 months agoinvesting.comAlnylam Pharmaceuticals stock falls on silencer drug concerns
3 months agoinvesting.comWhy is Alnylam Pharmaceuticals stock climbing today?
4 months agoinvesting.comWhy is Alnylam Pharmaceuticals stock surging today?
4 months agobarrons.comS&P 500 Futures Climb in Premarket Trading; Alnylam Pharmaceuticals, BridgeBio Pharma Lead
Alnylam Pharmaceuticals Top Trades
Alnylam Pharmaceuticals's top trade so far today returned +2.56%, while the top short trade returned -6.31%.
Alnylam Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $191.21 |
|---|---|
| 10 Day Moving Average (SMA10) | $209.06 |
| 20 Day Moving Average (SMA20) | $218.53 |
| 50 Day Moving Average (SMA50) | $234.91 |
| 100 Day Moving Average (SMA100) | $250.77 |
| 200 Day Moving Average (SMA200) | $284.46 |
Alnylam Pharmaceuticals Statistics
| Average Volume (30 Days) | 1.49M |
|---|---|
| P/E Ratio (Current) | 38.52 |
| EPS (Current) | $6.04 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $793.95M |
| Cash Ratio | 1.13 |
| Current Ratio | 3.05 |
| Quick Ratio | 2.99 |
| Debt to Equity | 0.75 |
| Enterprise Value | $30.44B |
| EV to EBITDA | 28.86 |
| EV to Sales | 6.34 |
| Price to Book | 22.99 |
| Price to Cash Flow | 35.15 |
| Price to Free Cash Flow | 39.22 |
| Price to Sales | 6.48 |
| Return on Assets | 0.15% |
| Return on Equity | 0.60% |
Alnylam Pharmaceuticals Stock Splits
There have been no stock splits for Alnylam Pharmaceuticals (ALNY).
Alnylam Pharmaceuticals Dividends
There have been no dividends for Alnylam Pharmaceuticals (ALNY).